Continuous Glucose Monitoring Contact Lens GlucoseLens Deep Dive: Non-Invasive Blood Sugar Monitoring Through Tears
Google life sciences division Verily releases continuous glucose monitoring contact lens GlucoseLens, achieving non-invasive continuous blood glucose monitoring by detecting glucose concentration in tears, with 92% accuracy compared to traditional fingerstick testing.
On January 17, 2030, Google's life sciences company Verily released the continuous glucose monitoring contact lens GlucoseLens. This daily disposable contact lens embeds a micro glucose sensor and wireless communication chip, achieving non-invasive continuous blood glucose monitoring through tear fluid glucose detection.
In clinical trials with 500 diabetic patients, GlucoseLens achieved a correlation coefficient of 0.92 with traditional fingerstick readings — clinically usable accuracy. The lens measures automatically every 5 minutes, 24 hours uninterrupted. Priced at $99/month, expected to launch Q3 2030 in the US.
Disclaimer
Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.